These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 11393591

  • 1. Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model.
    Montgomery SA, Loft H, Sánchez C, Reines EH, Papp M.
    Pharmacol Toxicol; 2001 May; 88(5):282-6. PubMed ID: 11393591
    [Abstract] [Full Text] [Related]

  • 2. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder.
    Lepola U, Wade A, Andersen HF.
    Int Clin Psychopharmacol; 2004 May; 19(3):149-55. PubMed ID: 15107657
    [Abstract] [Full Text] [Related]

  • 3. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.
    Lepola UM, Loft H, Reines EH.
    Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155
    [Abstract] [Full Text] [Related]

  • 4. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.
    Clin Drug Investig; 2007 Jul; 27(7):481-92. PubMed ID: 17563128
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 6. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder.
    Moore N, Verdoux H, Fantino B.
    Int Clin Psychopharmacol; 2005 May; 20(3):131-7. PubMed ID: 15812262
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.
    Colonna L, Andersen HF, Reines EH.
    Curr Med Res Opin; 2005 Oct; 21(10):1659-68. PubMed ID: 16238906
    [Abstract] [Full Text] [Related]

  • 8. The effect of escitalopram on sleep problems in depressed patients.
    Lader M, Andersen HF, Baekdal T.
    Hum Psychopharmacol; 2005 Jul; 20(5):349-54. PubMed ID: 15912558
    [Abstract] [Full Text] [Related]

  • 9. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J, Goa KL.
    CNS Drugs; 2003 Jul; 17(5):343-62. PubMed ID: 12665392
    [Abstract] [Full Text] [Related]

  • 10. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
    Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M.
    Curr Med Res Opin; 2006 Jul; 22(7):1331-41. PubMed ID: 16834832
    [Abstract] [Full Text] [Related]

  • 11. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM, Llorca PM, Despiegel N, Verpillat P.
    Encephale; 2004 Jul; 30(2):158-66. PubMed ID: 15107719
    [Abstract] [Full Text] [Related]

  • 12. Combining escitalopram with gaboxadol provides no additional benefit in the treatment of patients with severe major depressive disorder.
    Kasper S, Ebert B, Larsen K, Tonnoir B.
    Int J Neuropsychopharmacol; 2012 Jul; 15(6):715-25. PubMed ID: 22008735
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
    Llorca PM, Azorin JM, Despiegel N, Verpillat P.
    Int J Clin Pract; 2005 Mar; 59(3):268-75. PubMed ID: 15857321
    [Abstract] [Full Text] [Related]

  • 14. Escitalopram continuation treatment prevents relapse of depressive episodes.
    Rapaport MH, Bose A, Zheng H.
    J Clin Psychiatry; 2004 Jan; 65(1):44-9. PubMed ID: 14744167
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT.
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [Abstract] [Full Text] [Related]

  • 16. Escitalopram versus placebo in the treatment of dysthymic disorder.
    Hellerstein DJ, Batchelder ST, Hyler S, Arnaout B, Toba C, Benga I, Gangure D.
    Int Clin Psychopharmacol; 2010 May; 25(3):143-8. PubMed ID: 21811192
    [Abstract] [Full Text] [Related]

  • 17. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials.
    Gorman JM, Korotzer A, Su G.
    CNS Spectr; 2002 Apr; 7(4 Suppl 1):40-4. PubMed ID: 15131492
    [Abstract] [Full Text] [Related]

  • 18. Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine.
    Bose A, Tsai J, Li D.
    Clin Drug Investig; 2012 Jun 01; 32(6):373-85. PubMed ID: 22559255
    [Abstract] [Full Text] [Related]

  • 19. The onset of effect for escitalopram and its relevance for the clinical management of depression.
    Wade A, Friis Andersen H.
    Curr Med Res Opin; 2006 Nov 01; 22(11):2101-10. PubMed ID: 17076970
    [Abstract] [Full Text] [Related]

  • 20. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ, Gergel I, Bose A.
    J Clin Psychiatry; 2002 Apr 01; 63(4):331-6. PubMed ID: 12000207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.